Stevens Johnson syndrome (SJS) is an acute inflammatory skin condition.
SJS is on a spectrum of disease with toxic epidermal necrolysis (TEN) at the more severe end. Terminology depends on how much of the body surface area is involved 1,2:
- SJS: <10%
- SJS-TEN overlap: 10-30%
- TEN: >30%
SJS is very rare, with an incidence of 1-2 per 1,000,000 3.
Stevens Johnson syndrome is thought to be triggered by preceding viral infection or more commonly medication use (e.g. NSAIDs, antibiotics, anticonvulsants). Skin and mucosal surface (e.g. gastrointestinal, genital, conjunctival) with blistering and shedding is characteristic 1-3.
- 1. Gerull R, Nelle M, Schaible T. Toxic epidermal necrolysis and Stevens-Johnson syndrome: a review. Crit. Care Med. 2011;39 (6): 1521-32. doi:10.1097/CCM.0b013e31821201ed - Pubmed citation
- 2. Worswick S, Cotliar J. Stevens-Johnson syndrome and toxic epidermal necrolysis: a review of treatment options. Dermatol Ther. 2011;24 (2): 207-18. doi:10.1111/j.1529-8019.2011.01396.x - Pubmed citation
- 3. Harr T, French LE. Toxic epidermal necrolysis and Stevens-Johnson syndrome. Orphanet J Rare Dis.5 (1): 39. doi:10.1186/1750-1172-5-39 - Free text at pubmed - Pubmed citation